Simple Three-Factor Score Predicts Who Can Finish R-CHOP Therapy in Older Lymphoma Patients
A retrospective study of 117 older patients with diffuse large B-cell lymphoma identified age, performance status and serum albumin as ...
A retrospective study of 117 older patients with diffuse large B-cell lymphoma identified age, performance status and serum albumin as ...
A small retrospective study found that metastatic colorectal cancer patients whose tumors carried only rare, non-hotspot RAS or RAF mutations ...
A retrospective study of 112 DLBCL patients found that a composite HALP-LDH score predicted overall survival more accurately than either ...
A prospective Guinean study of 55 patients found that failed urinary drainage in cervical cancer-related obstructive renal failure was linked ...
A study of 73 treatment-naïve patients with HIV-associated Kaposi sarcoma found that baseline blood levels of eotaxin, interleukin-6 and interleukin-8 ...
A retrospective study of 99 patients found that a low preoperative modified Geriatric Nutritional Risk Index, which combines C-reactive protein ...
A retrospective study of 250 patients developed a nomogram using age, EGFR genotype, CYFRA21-1 level, and TKI generation to predict ...
B7-H6 expression on tumor cells and tumor-infiltrating leukocytes is linked to metastasis, lymph node spread and reduced overall survival in ...
A single-center retrospective analysis of 40 patients with relapsed AL amyloidosis found that daratumumab monotherapy produced hematologic responses in 72.5 ...
A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...
A retrospective US cohort of 2,694 pancreatic cancer patients found MTAP deletion in 30.5 percent of tumors and consistently lower ...
A prospective study of 48 patients links dual-tracer FDG and FAPI-04 PET/CT measurements to aggressive pathological features and survival in ...
A Phase 3 trial found the next-generation KRAS G12C inhibitor divarasib extended median overall survival to 17.7 months versus 12 ...
A new review finds that combining immune-checkpoint inhibitors with locoregional therapies improves progression-free survival in hepatocellular carcinoma, but overall survival ...
A phase II trial reports 11.9-month median overall survival with CIMAvax-EGF plus nivolumab in previously treated advanced NSCLC, with the ...
A meta-analysis of fourteen retrospective cohorts finds that dynamic skeletal muscle deterioration during hepatocellular carcinoma treatment is associated with an ...
A retrospective Eastern Indian cohort study found that children with ALL who had detectable end-of-induction measurable residual disease had significantly ...
A retrospective study of 56 Chinese patients aged 60 and older found PD-1 inhibitor rechallenge after prior immunotherapy produced a ...
A retrospective study of 642 patients found bone metastases in 37.1 percent of metastatic neuroendocrine tumors and linked them to ...
A meta-analysis of 46 studies finds that high expression of oncogenic circular RNAs is associated with poorer overall survival in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.